Capital Fund Management (CFM)
GSK icon

Capital Fund Management (CFM)’s GSK GSK Stock Holding History

Capital Fund Management (CFM)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26M Sell
22,900
-55,100
-71% -$2.99M 0.01% 1581
2025
Q4 		$3.83M Sell
78,000
-32,100
-29% -$1.5M 0.01% 1334
2025
Q3 		$4.75M Buy
110,100
+18,800
+21% +$734K 0.01% 1284
2025
Q2 		$3.51M Sell
91,300
-82,600
-47% -$3.16M 0.01% 1362
2025
Q1 		$6.74M Sell
173,900
-18,900
-10% -$692K 0.02% 870
2024
Q4 		$6.52M Buy
192,800
+119,700
+164% +$4.31M 0.02% 959
2024
Q3 		$2.99M Buy
+73,100
New +$2.99M 0.01% 1255
2023
Q1 		– Sell
-46,300
Closed -$1.63M – 1636
2022
Q4 		$1.63M Buy
46,300
+8,300
+22% +$276K 0.01% 1005
2022
Q3 		$1.12M Buy
+38,000
New +$1.44M 0.01% 1048
2022
Q1 		– Sell
-9,200
Closed -$507K – 1578
2021
Q4 		$507K Buy
+9,200
New +$479K ﹤0.01% 1440
2018
Q1 		– Sell
-4,880
Closed -$216K – 1964
2017
Q4 		$216K Sell
4,880
-4,240
-46% -$196K ﹤0.01% 1724
2017
Q3 		$463K Buy
+9,120
New +$463K ﹤0.01% 1193
2015
Q2 		– Sell
-4,480
Closed -$258K – 1553
2015
Q1 		$258K Sell
4,480
-23,520
-84% -$1.35M ﹤0.01% 1294
2014
Q4 		$1.5M Buy
28,000
+10,080
+56% +$564K 0.02% 775
2014
Q3 		$1.03M Buy
+17,920
New +$1.1M 0.01% 919
2014
Q2 		– Sell
-5,520
Closed -$369K – 1767
2014
Q1 		$369K Sell
5,520
-45,920
-89% -$3.1M ﹤0.01% 1370
2013
Q4 		$3.43M Sell
51,440
-7,920
-13% -$514K 0.04% 512
2013
Q3 		$3.72M Buy
+59,360
New +$3.82M 0.05% 438

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital Fund Management (CFM)'s GSK Position: Q1 2025 in Review

Capital Fund Management (CFM) sold out of GSK (GSK) in Q1 2025, closing a stake of 285,867 shares — an estimated $10.5M sold.

Capital Fund Management (CFM) first reported a position in GSK in Q1 2014 and held it in 23 quarters. The position peaked at $23.3M in Q4 2022. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Capital Fund Management (CFM) reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 285,867 GSK shares in Q1 2025, an estimated $10.5M.
  • Capital Fund Management (CFM) first reported a position in GSK in Q1 2014 and held it in 23 quarters.
  • Capital Fund Management (CFM)'s GSK position peaked at $23.3M in Q4 2022.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2025, filed 14 May 2025.